EP2194987
Nýir stat3 hemlar á brautir og krabbameinsstofnfrumur
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.9.2008EP published:
18.5.2016EP application number:
08830471.2
EP translation filed:
7.6.2016Grant published:
15.7.2016EPO information:
European Patent Register
Max expiry date:
9.9.2028Expiry date:
9.9.2019
Title:
NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS
Timeline
Today
10.9.2008EP application
18.5.2016EP Publication
7.6.2016Translation submitted
15.7.2016Registration published
9.9.2019Expires
Owner
Name:
Boston Biomedical, Inc.Address:
640 Memorial Drive, 02139, Cambridge, MA, US
Inventor
Name:
JIANG, ZhiweiAddress:
StowMA, US
Name:
LI, Chiang, JiaAddress:
Cambridge, MA, US
Name:
LI, WeiAddress:
WaylandMA, US
Name:
LEGGETT, DavidAddress:
MiltonMA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
971144 PDate:
10.9.2007Country:
US
Number:
13372Date:
13.12.2007Country:
US
Classification
Categories:
A61K 31/505, A61K 31/55, A61K 38/17
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.8.2016
Expires: 9.9.2017
Payer: Árnason Faktor
Number: 10
Paid: 19.3.2018
Expires: 9.9.2018
Payer: Guðjón Styrkársson, hrl.
Number: 11
Paid: 13.8.2018
Expires: 9.9.2019
Payer: Örn Þór, slf.